OMC
TNGX icon

Oasis Management Company’s Tango Therapeutics TNGX Stock Holding History

Oasis Management Company’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-117,000
Closed -$848K – 109
2022
Q4 		$848K Hold
117,000
– – 0.17% 52
2022
Q3 		$424K Hold
117,000
– – 0.07% 92
2022
Q2 		$530K Buy
+117,000
New +$708K 0.09% 86

Other funds holding TNGX

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Oasis Management Company's TNGX Position: Q1 2023 in Review

Oasis Management Company sold out of Tango Therapeutics (TNGX) in Q1 2023, closing a stake of 117,000 shares — an estimated $848K sold.

Oasis Management Company first reported a position in TNGX in Q2 2022 and held it in 3 quarters. The position peaked at $848K in Q4 2022. 92 funds tracked by Wall St. Rank hold TNGX as of Q1 2023.

  • Oasis Management Company reported no remaining Tango Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Oasis Management Company sold 117,000 Tango Therapeutics shares in Q1 2023, an estimated $848K.
  • Oasis Management Company first reported a position in Tango Therapeutics in Q2 2022 and held it in 3 quarters.
  • Oasis Management Company's Tango Therapeutics position peaked at $848K in Q4 2022.
  • 92 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2023.

Based on Oasis Management Company's 13F filing for Q1 2023, filed 15 May 2023.